SCHEMBL6603848

SCHEMBL6603848

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OCC1CCCN1C(=O)CO

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.74
ERBB2 P04626 9/20 0.65
EPHA2 P29317 2/20 0.63
EPHB4 P54760 2/20 0.63
GAK O14976 1/20 0.63
RIPK2 O43353 1/20 0.63
LYN P07948 1/20 0.63
RET P07949 1/20 0.63
EPHA1 P21709 1/20 0.63
ERBB3 P21860 1/20 0.63
EPHB2 P29323 1/20 0.63
EPHA5 P54756 1/20 0.63
EPHA4 P54764 1/20 0.63
ADK P55263 1/20 0.63
PTK6 Q13882 1/20 0.63
RIPK3 Q9Y572 1/20 0.63
KDR P35968 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129240 1.00 EGFR (0.74) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3123266 0.94 EGFR (0.68) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL6605869 0.94 EGFR (0.68) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3126784 0.93 EGFR (0.67) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL6607570 0.93 EGFR (0.67) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3129482 0.92 EGFR (0.70) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3129181 0.92 EGFR (0.70) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL6606075 0.92 EGFR (0.70) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL6605015 0.92 EGFR (0.65) EGFRERBB2EPHA2EPHB4GAK
SCHEMBL3133415 0.92 EGFR (0.65) EGFRERBB2EPHA2EPHB4GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487806-A1 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS Astrazeneca AB (SE) 2004-12-22 EP disclosed
WO-2003082831-A1 4-ANILINO QUINAZOLINE DERIVATIVES AS ANTIPROLIFERATIVE AGENTS ASTRAZENECA AB (SE) 2003-10-09 WO disclosed